Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001209191-21-055663

General Counsel sold 2,000 shares at an average $35.93 ($71,860)

  • General Counsel acquired 2,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Ring Christine · General Counsel

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2021-09-10 Exercise or conversion : show line 1 in the form +2,000 $1.86 $3,720 3,286 D
2021-09-10 Sale : show line 2 in the form −700 $35.10 $24,568 2,586 D
2021-09-10 Sale : show line 3 in the form −500 $35.77 $17,884 2,086 D
2021-09-10 Sale : show line 4 in the form −800 $36.76 $29,408 1,286 D
Open-market sales · 2,000 sh · avg $35.93 · $71,860

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-09-10 Exercise or conversion : show line 5 in the form Employee Stock Option (right to buy) −2,000 105,666 D
Loading xslF345X03/doc4.xml…